McCarthy Bertschy is delighted to announce that Ms. Martha Kadas recently joined Sterigenics International as Global Vice President of Quality. She will report directly to Mr. Michael Mulhern, Chief Executive Officer.
Martha joined Sterigenics from Natus Medical, Inc. where she was Director of Quality Assurance and Regulatory Affairs. A quality leader with extensive experience in a regulated environment, Martha's prior experience includes roles of increasing responsibility at Fenwal, Inc., Baxter International and Abbott Laboratories. She holds degrees in Biology and Psychology from the University of Illinois at Urbana-Champaign. Martha is a Six Sigma Black Belt, an American Society of Quality (ASQ) Senior Member, and a Quality and Reliability Engineer.
About Sterigenics International
Sterigenics International is a world leader in contract sterilization and ionization services. For over 50 years, Sterigenics has delivered safer, smarter and more productive contract sterilization solutions to the medical device and pharmaceutical industries using Ethylene Oxide (EO), Gamma and Electron Beam (E-Beam) irradiation. The company also provides process capabilities for food safety and high performance/specialty materials using Gamma and Electron Beam radiation technologies. Sterigenics employs approximately 1,300 professionals and operates 38 facilities across North America, Europe and Asia.
The company's corporate headquarters are in Oak Brook, IL. In 2011, Silverfleet Capital and PPM America Capital Partners sold Sterigenics to GTCR LLC, a Chicago-based private equity firm. For further information, please see www.sterigencis.com.
About McCarthy Bertschy & Associates
McCarthy Bertschy & Associates is a collaborative, retained executive search firm led by experienced, results-driven Partners. Senior Partners personally execute engagements, assuring clients of informed advice and counsel throughout the process. Our client base includes public and private companies, as well as private equity firms and their portfolio investments.
Please view our new website at www.mccarthybertschy.com